Regeneron Pharmaceuticals
REGN
#192
Rank
S$120.74 B
Marketcap
$1,099
Share price
0.48%
Change (1 day)
1.06%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$10.76 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are S$10.76 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$9.38 B6.89%
2022-12-31S$8.78 B-2.55%
2021-12-31S$9.01 B10.98%
2020-12-31S$8.12 B62.11%
2019-12-31S$5.00 B23.16%
2018-12-31S$4.06 B16.06%
2017-12-31S$3.50 B-4.07%
2016-12-31S$3.65 B32.16%
2015-12-31S$2.76 B62.51%
2014-12-31S$1.70 B34.41%
2013-12-31S$1.26 B23.93%
2012-12-31S$1.02 B-5.88%
2011-12-31S$1.08 B49.99%
2010-12-31S$0.72 B49.61%
2009-12-31S$0.48 B11.7%
2008-12-31S$0.43 B-36.8%
2007-12-31S$0.68 B21.23%
2006-12-31S$0.56 B9.64%
2005-12-31S$0.51 B8.71%
2004-12-31S$0.47 B-18.4%
2003-12-31S$0.58 B36.32%
2002-12-31S$0.42 B0.5%
2001-12-31S$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$110.56 B 927.06%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.53 B-48.59%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.47 B 34.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$143.42 B 1,232.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$79.69 B 640.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$80.70 B 649.68%๐Ÿ‡ซ๐Ÿ‡ท France